A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.

Proc Natl Acad Sci U S A · 2020 · PMC7768780 · PMID 33257540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In contrast, growth of MeV vac2 -SARS2-S(H) was much closer to MV vac2 -ATU(P), with only a slight trend for lower titers ( Fig. 1 C and D ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.